Hospira (HSP) operated as the hospital products business of Abbott Laboratories until it was spun off into a stand-alone entity in 2004. Today, the company manufactures generic specialty injectable drugs, infusion pumps and other medical services, across thirteen manufacturing facilities globally generating $4.1 billion in annual sales. In 2012 the Americas accounted for 79% of net sales while EMEA and APAC generated 13% and 8% of revenues, respectively. By product, specialty injectable pharmace...
Hospira (HSP) operated as the hospital products business of Abbott Laboratories until it was spun off into a stand-alone entity in 2004. Today, the company manufactures generic specialty injectable drugs, infusion pumps and other medical services, across thirteen manufacturing facilities globally generating $4.1 billion in annual sales. In 2012 the Americas accounted for 79% of net sales while EMEA and APAC generated 13% and 8% of revenues, respectively. By product, specialty injectable pharmace...
Share this Article
Recommended